Future clinical oncology publications

Updates of existing guidance

Timely delivery of radical radiotherapy: guidelines for the management of unscheduled treatment interruptions (fifth edition)

• View current edition
  Change due to be published to early 2024.

New resources in development

Consensus statements for gynaecological cancer

A steering group of gynaecological cancer experts has been recruited to lead on the development of consensus statements aimed at reducing variation in gynaecological cancer practice.

Final statements expected early 2024.

Principles of re-irradiation

There is an increasing utilisation of a second course of radiotherapy to treat recurrent or relapsed disease. The RCR has identified this as an emerging important area of clinical activity and research which would benefit from a top-level guidance document to guide practitioners.

Due to be published by early 2024.


Combined chemo/radiotherapy consent forms

‘The RCR continues to develop national site-specific combined chemo-radiotherapy consent forms and are currently producing consent forms for prostate brachytherapy, bladder radiotherapy and central nervous system radiotherapy.

Due to be published early 2024.

View the latest updates on all the RCR’s radiotherapy consent forms.

Radiotherapy contouring for vulva cancer

The RCR audit on vulva radiotherapy in 2020 showed there was a wide variety of practice for vulvar cancer radiotherapy and people are often confused by target, margins and dose.

The RCR convened a panel of experts, alongside consultation from a contouring panel, consisting of clinical oncologists with a wide range of experience treating vulval cancers, to help develop recommendations which aim to standardise national treatment in vulva contouring across the UK.

Due to be published in early 2024.